Search

Headquarters

Contact Us

  • (+01) 512 835 8026
  • info@myriadrbm.com
  • 3300 Duval Road
    Austin, TX 78759
    USA
  • Mon to Fri - 8:50am to 5:00pm

Ready to order?

Great! Every order starts with a quote.

Get Started

  • (+01) 512 835 8026
  • info@myriadrbm.com
Get a Quote Contact | FAQ's | Blog
Myriad RBM Myriad RBM

Innovative Biomarker Solutions

Toggle menu

Skip to content
  • About Us
    • About Myriad RBM

      Myriad RBM’s CLIA certified biomarker testing laboratory, is located in Austin, TX. Myriad RBM is a wholly owned subsidiary of Myriad Genetics, Inc. (MYGN), a leading molecular diagnostic company based in Salt Lake City, Utah which develops and markets novel predictive medicine, personalized medicine and prognostic medicine tests.
    • About Myriad RBM

      • About Us
      • Management
      • Quality Policy
      • Employment
      • Partners
      • Sales Team
      • Certifications
    • Newsroom

      • Press
      • Company Newsletters
      • Conferences
      • Abstracts + Papers
      • Sign Up for Our Newsletter
      • Blog
    • Data Quality

      • Overview
      • Myriad RBM Technology
  • Biomarker Solutions
    • Solutions

      • Overview
      • Assay Change Log

      CustomMAP

      If a smaller, more focused panel of analytes is required, we can build a Custom MAP to meet your needs.

      Learn More »

      TruCulture Spike

    • Multiplexed Immunoassays

      • Full Biomarker Menu
      • DiscoveryMAP® v. 4.0
      • ExplorerMAP™ v. 1.0
      • HumanMAP® v. 2.0
      • CardiovascularMAP® v. 3.0
      • AngiogenesisMAP® v. 1.0
      • InflammationMAP® v. 1.1
      • ImmunoMAP® v. 1.0
      • NeuroMAP™ v. 1.0
      • MetabolicMAP® v. 1.0
      • KidneyMAP®
      • CytokineMAP A
      • CytokineMAP B
      • SARS-CoV-2/COVID-19 Research
      • Cytokine Storm Testing for SARS-CoV-2/COVID-19 Research
      • SARS-CoV-2 Multiplex Serology
      Webinar Registration
    • TruCulture

      Whole Blood Collection and Culture System

      Learn More »
      Quanterix simoa

      Ultrasensitive immunoassays manufactured by Myriad RBM and based on Quanterix’s Simoa technology.

      Learn More »
  • Resources + Support
    • Resources

      • Bibliography
      • White Papers
      • Application Notes
      • Events
      • Webinars
      • Blog
      • COVID-19/SARS-CoV-2 Research Tools
    • Support

      • Client Services
      • Request a Biomarker
      • Speak to a Scientist
  • How to Order
    • Ordering Information

      • How to Order
      • Request a quote
      • Acceptable Samples
      • Frequently Asked Questions
    • Request Information

      • Contact Client Services
      • Request a Biomarker
      • Speak to a Scientist
    • Ready to Order?

      Great!

      Every order starts with a quote.

      Get Started

  •  

Category Archives: Cancer

22 May 2020

Bibliography Updates May 2020

May 22, 2020
Desiree Klingler-Gaston
Autoimmune and Arthritis, Blog, Cancer, Neuroscience and Neurological, Utilized Myriad RBM's Services
Myriad RBM’s biomarker testing services and TruCulture product have been cited in over 1000 peer-reviewed research articles.  As a CLIA-certified labo...
Read More
8 Jan 2020

Serum Biomarker Signature Correlates With Cancer Drug Clearance and Predicts Overall Survival

January 8, 2020
Desiree Klingler-Gaston
Blog, Cancer, Technology- Multi-Analyte Profile, Utilized Myriad RBM's Services
In a study published in the Journal for ImmunoTherapy of Cancer December 2019 issue1, researchers demonstrate that a baseline serum biomarker signatur...
Read More
14 Jan 2019
Serum tube

Inflammatory Markers Can Identify Non-Responders to Dendritic Vaccine

January 14, 2019
myriadrbm
Cancer, Cytokines and Chemokines, Inflammation
(Note: While the authors stated serum in the publication, the blood samples were collected in EDTA tubes. Thus, in the following summary, serum is cor...
Read More
16 Apr 2018

Supplement: Who Gets Immunotherapy for Cancer?

April 16, 2018
Scott Collier
Blog, Cancer, Press
Managing Patient Expectations Requires Better Biomarkers and Companion Diagnostics Read the full article at GEN News Improving Cancer Immunotherapy...
Read More
12 Dec 2017

Monitoring IFN-gamma Responses in Serum

December 12, 2017
Scott Collier
Blog, Cancer, Cytokines and Chemokines, Utilized Myriad RBM's Services
The Immunomodulatory Effects of Cancer Therapy on IFN-gamma Responses in the Periphery. (2017) Brunet LR, et al. SITC 2017 Annual Meeting; November 8...
Read More
21 Sep 2016

IL-10 (AM0010) phase I trial offers novel mechanism for immune-oncology drugs in solid tumors

September 21, 2016
myriadrbm
Cancer, Cytokines and Chemokines, Inflammation, Utilized Myriad RBM's Services
More commonly known as an inhibitory cytokine, high doses of interleukin 10 (IL-10) have been shown to lead to the activation and survival of antigen...
Read More
13 Jun 2016

Researchers in this immuno-oncology trial used Myriad RBM’s services to measure serum biomarkers.

June 13, 2016
myriadrbm
Cancer, Utilized Myriad RBM's Services
Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma The data presented in this paper shows baseline and on-treatment biomarkers...
Read More
1 2 3 4

Categories

  • Biomarkers (4)
  • Blog (135)
    • Autoimmune and Arthritis (10)
    • Cancer (28)
    • Cardiac (9)
    • Cytokines and Chemokines (20)
    • Diabetes (7)
    • Gastrointestinal (1)
    • Inflammation (42)
    • Neuroscience and Neurological (33)
    • News From the Lab (1)
    • Renal Function and Toxicity (8)
    • Technology- Multi-Analyte Profile (1)
    • TruCulture (2)
  • COVID-19 (2)
  • Press (38)
  • Utilized Myriad RBM's Services (43)

ABOUT MYRIAD RBM

Overview
Management
Quality Policy
Employment
Partners
Sales Team
Certifications

MAPs

Full Biomarker Menu
DiscoveryMAP® v. 3.3
ExplorerMAP™ v. 1.0
HumanMAP® v. 2.0
CardiovascularMAP® v. 3.0
AngiogenesisMAP® v. 1.0
InflammationMAP® v. 1.0
ImmunoMAP® v. 1.0
NeuroMAP™ v. 1.0
MetabolicMAP® v. 1.0
KidneyMAP®
CytokineMAP A
CytokineMAP B

RESOURCES

Bibliography
White Papers
Events
Webinars
Blog

SUPPORT

Customer Support
Speak to a Scientist
Assay Change Log
Request a Biomarker
FAQs

SOLUTIONS

Results Processing
Assay Development
Quality Control
Project Management

SERVICES

Multiplexed Assay Services
Ultrasensitive Assays
TruCulture

  • Jobs
  • Terms of Use
  • Privacy Practice
  • Analytes Listing
Copyright © 2021 Myriad RBM. All rights reserved. Myriad does not sell your personal information